M1FG
TWST icon

Mach-1 Financial Group’s Twist Bioscience TWST Stock Holding History

Mach-1 Financial Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,769
Closed -$344K – 303
2025
Q1 		$344K Buy
+8,769
New +$395K 0.1% 162

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Mach-1 Financial Group's TWST Position: Q2 2025 in Review

Mach-1 Financial Group sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 8,769 shares — an estimated $344K sold.

Mach-1 Financial Group first reported a position in TWST in Q1 2025 and held it in 1 quarter. The position peaked at $344K in Q1 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Mach-1 Financial Group reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Mach-1 Financial Group sold 8,769 Twist Bioscience shares in Q2 2025, an estimated $344K.
  • Mach-1 Financial Group first reported a position in Twist Bioscience in Q1 2025 and held it in 1 quarter.
  • Mach-1 Financial Group's Twist Bioscience position peaked at $344K in Q1 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Mach-1 Financial Group's 13F filing for Q2 2025, filed 11 Aug 2025.